GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medigen Biotechnology Corp (ROCO:3176) » Definitions » Operating Margin %

Medigen Biotechnology (ROCO:3176) Operating Margin % : 29.95% (As of Mar. 2025)


View and export this data going back to 2011. Start your Free Trial

What is Medigen Biotechnology Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Medigen Biotechnology's Operating Income for the three months ended in Mar. 2025 was NT$150 Mil. Medigen Biotechnology's Revenue for the three months ended in Mar. 2025 was NT$499 Mil. Therefore, Medigen Biotechnology's Operating Margin % for the quarter that ended in Mar. 2025 was 29.95%.

The historical rank and industry rank for Medigen Biotechnology's Operating Margin % or its related term are showing as below:

ROCO:3176' s Operating Margin % Range Over the Past 10 Years
Min: -207.13   Med: -149.87   Max: 19.57
Current: 4.73


ROCO:3176's Operating Margin % is ranked better than
76.55% of 981 companies
in the Biotechnology industry
Industry Median: -115.37 vs ROCO:3176: 4.73

Medigen Biotechnology's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Medigen Biotechnology's Operating Income for the three months ended in Mar. 2025 was NT$150 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2025 was NT$77 Mil.


Medigen Biotechnology Operating Margin % Historical Data

The historical data trend for Medigen Biotechnology's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medigen Biotechnology Operating Margin % Chart

Medigen Biotechnology Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -148.48 19.57 -155.86 -105.26 -15.35

Medigen Biotechnology Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -54.85 -6.85 0.92 -15.91 29.95

Competitive Comparison of Medigen Biotechnology's Operating Margin %

For the Biotechnology subindustry, Medigen Biotechnology's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medigen Biotechnology's Operating Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medigen Biotechnology's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Medigen Biotechnology's Operating Margin % falls into.


;
;

Medigen Biotechnology Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Medigen Biotechnology's Operating Margin % for the fiscal year that ended in Dec. 2024 is calculated as

Operating Margin %=Operating Income (A: Dec. 2024 ) / Revenue (A: Dec. 2024 )
=-210.718 / 1372.701
=-15.35 %

Medigen Biotechnology's Operating Margin % for the quarter that ended in Mar. 2025 is calculated as

Operating Margin %=Operating Income (Q: Mar. 2025 ) / Revenue (Q: Mar. 2025 )
=149.549 / 499.372
=29.95 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medigen Biotechnology  (ROCO:3176) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Medigen Biotechnology Operating Margin % Related Terms

Thank you for viewing the detailed overview of Medigen Biotechnology's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Medigen Biotechnology Business Description

Traded in Other Exchanges
N/A
Address
Yuancyu Street, 14F, Building No.3,, Nangang District, Taipei, TWN, 11560
Medigen Biotechnology Corp is a biopharmaceutical company engaged in new drug development, drug discovery, molecular diagnostics, vaccine, and generic drugs. The company has four segments: Nucleic acid department: segment, which derives maximum revenue, is responsible for services of testing reagents, instruments and inspection on behalf of others; New drug and vaccine research and development segment: responsible for the development and relevant services of new drugs and vaccine; Cytotherapy department: responsible for research and development and relevant services of cytotherapy; and Generic drug, aesthetic medicine product and dietary supplement segment is responsible for production and sales and relevant services of western medicine, aesthetic medicine product and dietary supplement.

Medigen Biotechnology Headlines

No Headlines